|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
US5262522A
(en)
|
1991-11-22 |
1993-11-16 |
Immunex Corporation |
Receptor for oncostatin M and leukemia inhibitory factor
|
|
PT672141E
(pt)
|
1992-10-23 |
2003-09-30 |
Immunex Corp |
Metodos de preparacao de proteinas oligomericas soluveis
|
|
US5457035A
(en)
|
1993-07-23 |
1995-10-10 |
Immunex Corporation |
Cytokine which is a ligand for OX40
|
|
US6133426A
(en)
|
1997-02-21 |
2000-10-17 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
|
JP3614866B2
(ja)
|
1997-06-12 |
2005-01-26 |
リサーチ コーポレイション テクノロジーズ，インコーポレイティド |
人工抗体ポリペプチド
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
CN1283228A
(zh)
|
1997-12-24 |
2001-02-07 |
武田药品工业株式会社 |
多肽、其生产方法及应用
|
|
US6210924B1
(en)
|
1998-08-11 |
2001-04-03 |
Amgen Inc. |
Overexpressing cyclin D 1 in a eukaryotic cell line
|
|
GB9928787D0
(en)
|
1999-12-03 |
2000-02-02 |
Medical Res Council |
Direct screening method
|
|
GB0025144D0
(en)
|
2000-10-13 |
2000-11-29 |
Medical Res Council |
Concatenated nucleic acid sequences
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
DE10138569A1
(de)
*
|
2001-08-06 |
2003-04-30 |
Bayer Ag |
Regulation des APJ-Rezeptors
|
|
US20040202995A1
(en)
|
2003-04-09 |
2004-10-14 |
Domantis |
Nucleic acids, proteins, and screening methods
|
|
WO2005106493A1
(en)
*
|
2004-04-30 |
2005-11-10 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled apelin receptor (apj)
|
|
US20060045880A1
(en)
|
2004-08-23 |
2006-03-02 |
Krieg Paul A |
Methods for modulating angiogenesis and apoptosis with apelin compositions
|
|
WO2012102363A1
(ja)
|
2011-01-28 |
2012-08-02 |
国立大学法人大阪大学 |
薬物送達システムおよびその利用
|
|
WO2013012855A1
(en)
*
|
2011-07-18 |
2013-01-24 |
Amgen Inc. |
Apelin antigen-binding proteins and uses thereof
|
|
US9556281B2
(en)
*
|
2011-08-15 |
2017-01-31 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein A
|
|
EA201591700A1
(ru)
*
|
2013-03-14 |
2015-12-30 |
Ридженерон Фармасьютикалз, Инк. |
Гибридные белки апелина и их применение
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
CA2931299C
(en)
*
|
2013-11-20 |
2024-03-05 |
Regeneron Pharmaceuticals, Inc. |
Aplnr modulators and uses thereof
|
|
AU2015233370A1
(en)
*
|
2014-03-20 |
2016-09-22 |
Centre National De La Recherche Scientifique (Cnrs) |
Use of compounds inhibiting Apelin / APJ / GP130 signaling for treating cancer
|
|
IL300029A
(en)
*
|
2014-05-16 |
2023-03-01 |
Baylor Res Institute |
Methods and preparations for the treatment of autoimmune and inflammatory conditions
|
|
US10463716B2
(en)
*
|
2014-10-13 |
2019-11-05 |
University Of Maryland, Baltimore |
Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone
|
|
ES3029413T3
(en)
*
|
2015-04-02 |
2025-06-24 |
Ablynx Nv |
Bispecific cxcr4-cd-4 polypeptides with potent anti-hiv activity
|
|
KR20200038311A
(ko)
*
|
2017-08-24 |
2020-04-10 |
페인스 테라퓨틱스 인코포레이티드 |
항-아펠린 항체 및 그의 용도
|